{"id":244372,"date":"2012-06-20T15:21:55","date_gmt":"2012-06-20T15:21:55","guid":{"rendered":"http:\/\/www.eugenesis.com\/neofax%c2%ae-neonatology-drug-and-enteral-nutrition-reference-book-discontinued-in-print-format-as-of-june-2012-now\/"},"modified":"2012-06-20T15:21:55","modified_gmt":"2012-06-20T15:21:55","slug":"neofax-neonatology-drug-and-enteral-nutrition-reference-book-discontinued-in-print-format-as-of-june-2012-now","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/neofax-neonatology-drug-and-enteral-nutrition-reference-book-discontinued-in-print-format-as-of-june-2012-now.php","title":{"rendered":"NeoFax\u00ae Neonatology Drug and Enteral Nutrition Reference Book Discontinued in Print Format as of June 2012; Now &#8230;"},"content":{"rendered":"<p><p>    GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--  <\/p>\n<p>    Truven Health Analytics, formerly the healthcare business of    Thomson Reuters, today announced the discontinuation of the    print format of the NeoFax drug and enteral nutrition    reference handbook. Previously distributed through online and    retail book sellers by Physician Desk Reference Inc (PDR), the    printed version of the manual available now is the Updated    Twenty-Fourth Edition, NeoFax 2011. The book was last    published in June 2011. As of June 2012, the print format of    the manual will not be updated, reprinted or further    distributed in book form. Instead, the company will focus    solely on the continued enhancement and distribution of its    Web-based installed and online solution, available through a    subscription to individuals, and to institutions through    enterprise licensing subscriptions. The     Micromedex NeoFax Online and Premier    subscriber-solutions include many enhancements which were not    available in the printed book. For a limited time,     NeoFax Online will be available to new subscribers    at introductory pricing. Please visit     <a href=\"http:\/\/www.neofax.com\" rel=\"nofollow\">http:\/\/www.neofax.com<\/a> for more information.  <\/p>\n<p>    NeoFax has been the trusted source of neonatal drug information    for more than 20 years, covering more than 180 drugs commonly    used to treat neonates. Many of these drugs and their    indications for use in the neonatal population are considered    off-label, making this resource invaluable for clinicians    caring for this vulnerable population. The NeoFax Solution    addresses the essential needs of neonatal medical professionals    to appropriately prescribe, calculate dosing, formulate and    administer critical drug therapy and parenteral nutrition for    neonates. As a result, NeoFax is the established source of    clinical decision support in Neonatal Intensive Care Units    (NICUs) around the world. As the foremost drug and nutrition    support solution, NeoFax aids in the treatment of neonates and    helps to improve patient safety. By eliminating the need to do    manual calculations and providing warning messages for dosing    or nutrition orders that fall outside of guidelines, NeoFax    helps to reduce errors. NeoFax also improves efficiencies by    decreasing the time spent calculating and ordering medication    and parenteral nutrition.  <\/p>\n<p>    The NeoFax Web-based Solution, first made available in    September 2006, is currently used by more than 1,100 hospitals    and health systems in the United States and internationally.    This solution provides hospitals and neonatal clinicians with    additional tools and more regularly updated content than the    printed NeoFax manual.  <\/p>\n<p>    NeoFax Premier is intuitive, reliable, and easily customizable    to your institutions concentrations and dosing. Unlike using a    printed reference book, NeoFax provides us with powerful    calculator warning messages for any abnormal ranges, to help    our clinicians avoid costly errors and make confident    decisions. These tools provide the peace of mind we need when    caring for our most vulnerable patients, said Jennifer Spiegel    RNC, BSN, MAS, NICU Nurse Manager, Saint Barnabas Medical    Center.  <\/p>\n<p>    NeoFax Online and Premier Solutions provide clinicians with the    tools to make accurate and informed treatment decisions, while    minimizing errors in this vulnerable patient population. Using    the NeoFax Solutions, clinicians can safely and accurately    provide patient- and indication-specific drug dosing, perform    parenteral nutrition calculations, and access trusted,    evidence-based, neonatal-specific drug information.  <\/p>\n<p>    Features Available in the Web-based NeoFax Online and NeoFax    Premier Include:  <\/p>\n<p>    In addition to our NeoFax Solutions, Micromedex Pediatrics    Solution is also now available. Pediatrics leverages the NeoFax    application, but is for infants and children ages 29 days to 18    years. Both the NeoFax and Pediatrics Solutions can be added to    an existing Micromedex subscription. For information on NeoFax    or Pediatrics Online or Premier, please call 1-888-612-2964    or visit     <a href=\"http:\/\/www.neofax.com\" rel=\"nofollow\">http:\/\/www.neofax.com<\/a>.  <\/p>\n<p>    About Truven Health Analytics:  <\/p>\n<p>    Truven Health Analytics delivers unbiased information, analytic    tools, benchmarks and services to the healthcare industry.    Hospitals, government agencies, employers, health plans,    clinicians, and pharmaceutical companies have relied on its    solutions for over 30 years. Truven Health Analytics combines    deep clinical, financial and healthcare management expertise    with innovative technology platforms and information assets to    make healthcare better, collaborating with customers to uncover    and realize opportunities for improving quality, efficiency,    and outcomes. Truven Health Analytics employs    approximately 2,200 people worldwide and has its principal    offices in Ann Arbor, Chicago and Denver.  <\/p>\n<\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/neofax-neonatology-drug-enteral-nutrition-131500117.html;_ylt=A2KJjamI6uFPI3kALSX_wgt.\" title=\"NeoFax\u00ae Neonatology Drug and Enteral Nutrition Reference Book Discontinued in Print Format as of June 2012; Now ...\">NeoFax\u00ae Neonatology Drug and Enteral Nutrition Reference Book Discontinued in Print Format as of June 2012; Now ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Truven Health Analytics, formerly the healthcare business of Thomson Reuters, today announced the discontinuation of the print format of the NeoFax drug and enteral nutrition reference handbook. Previously distributed through online and retail book sellers by Physician Desk Reference Inc (PDR), the printed version of the manual available now is the Updated Twenty-Fourth Edition, NeoFax 2011 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/neofax-neonatology-drug-and-enteral-nutrition-reference-book-discontinued-in-print-format-as-of-june-2012-now.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577479],"tags":[],"class_list":["post-244372","post","type-post","status-publish","format-standard","hentry","category-nutrition"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244372"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=244372"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244372\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=244372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=244372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=244372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}